Upcoming Events

• Personalised diagnostics and patient stratification

• Convergence therapies and interventions, and

• Therapy and recurrence monitoring.

No pre-registration required, just join the live session online.

Objective: To provide an overview of how economic evaluation is practically integrated into clinical trial design.

Target Audience: Clinical researchers, trial managers, other researchers seeking to understand what including an economic evaluation in a clinical trial involves from a practical perspective.

Activities:

• Explore case studies where economic endpoints were included in a clinical trial.
• Discuss implications at across all stages of a project – funding application, study design, data collection, analysis and reporting.

The Summit will feature dynamic sessions exploring:

• The current landscape of technology in dementia care
• Key gaps and opportunities for future research
• Funding pathways for dementia-focussed technologies
• Public and professional involvement
• Industry and start-up perspectives on technology development

As the session is in-person only and restricted by room capacity, pre-registration will be required and group size will be limited to a maximum of 20 on a first-come, first-served basis when sign-up opens. We advise sign-up only for those who can commit to attending and engaging with the full session.

Objective: To provide a clear and comprehensive introduction to conducting economic evaluations, tailored for participants with no prior experience. The content is designed to be relevant and applicable across both high-income and low-income settings.

Target Audience: Individuals new to economic evaluation, including students, early-career professionals and practitioners from clinical, policy or research backgrounds.

Structure: This interactive session will cover the following core topics:

• Introduction to economic evaluation: purpose, scope and relevance in health decision-making.
• Key components of an economic evaluation: framing the evaluation, defining comparators and choosing perspectives.
• Types of costs: the different types of cost (such as financial and economic), how they are measured and valued.
• Effectiveness metrics: overview of QALY and DALY outcome measures.
• Cost-effectiveness ratios: interpreting ICERs and understanding thresholds.
• Modelling approaches: basic principles of decision-analytic modelling.
• Cost-effectiveness vs. cost-benefit analysis: comparing frameworks and their policy implications.
• Key messages and questions.

As the session is in-person only and restricted by room capacity, pre-registration will be required and group size will be limited to a maximum of 20 on a first-come, first-served basis when sign-up opens. We advise sign-up only for those who can commit to attending and engaging with the full session.

Objective: Facilitate collaboration between:

• Innovators, clinicians and researchers looking for economic evaluation expertise.
• Health economists open to exploring collaboration and partnerships.

Target Audience: Individuals/groups seeking to forge new connections to supply or seek economic evaluation expertise.  

Structure:

• Explain the matchmaking goals.
• Quick 3-minute project pitches from participants to get familiar with each other’s work and identify potential matches for collaboration.
• Discussion guides/prompts provided.
• Participants rotate through 5-7-minute conversations, according to own relevance and interests.
• Self-organise follow-up session or informal networking to deepen promising connections.